Details
Stereochemistry | RACEMIC |
Molecular Formula | C13H13N3O3 |
Molecular Weight | 259.2606 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1CC(=O)NN=C1C2=CC3=C(NC(=O)CO3)C=C2
InChI
InChIKey=XZPGINPFWXLYNW-UHFFFAOYSA-N
InChI=1S/C13H13N3O3/c1-7-4-11(17)15-16-13(7)8-2-3-9-10(5-8)19-6-12(18)14-9/h2-3,5,7H,4,6H2,1H3,(H,14,18)(H,15,17)
Molecular Formula | C13H13N3O3 |
Molecular Weight | 259.2606 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2153210
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2153210
Bemoradan (RWJ-22867), a potent positive inotropic agent, inhibits cardiac phosphodiesterase fraction III. This compound was developed for the management of congestive heart failure. However, the information about the nowadays study of bemoradan is not available.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Simultaneous monitoring of bemoradan pharmacokinetics and hemodynamics in mongrel dogs. | 1992 Oct |
|
Pharmacokinetics and bioavailability of bemoradan, a long-acting inodilator in healthy males. | 1994 Feb |
|
Evaluation of the excretion, and metabolism of the cardiotonic agent bemoradan in male rats and female beagle dogs. | 2001 Oct-Dec |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8004360
bemoradan HCL salt in capsules. 0.5, 1, 1.5 and 2 mg of bemoradan
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:57:25 GMT 2023
by
admin
on
Fri Dec 15 15:57:25 GMT 2023
|
Record UNII |
G2S2V1ETBQ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C744
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5362399
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
AA-49
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
SUB05695MIG
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
C062457
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
CHEMBL46765
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
100000086569
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
6422
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
112018-01-6
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
C76314
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
G2S2V1ETBQ
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |